-+ 0.00%
-+ 0.00%
-+ 0.00%

The Tokyo Stock Exchange saw Sumitomo Pharma temporarily rise by 6%. This was due to a leukemia drug candidate being designated for the accelerated review system in the US.

NIKKEI QUICK·10/27/2026 06:09:03

Please log in to view news